Case Study

How To Enroll 612 Patients In A Neurology Study On Time And Within Budget Despite Hurdles Caused By The Pandemic

Source: OCT Clinical
Blog-Cellular-Therapy-in-Neurological-Diseases-1

Dr. Reddy's, a leading Indian pharmaceutical manufacturer, in partnership with OCT Clinical, an Eastern European CRO, launched a Ph3 neurology study. Despite pandemic-driven uncertainty, the enrollment target of 612 patients was reached within an impressive seven months. Through overcoming many challenges in order to figure out a cohesive strategy and solution, the teams, even within the hurdles caused by the COVID-19 nightmare, managed to undertake all activities within the project on time and complete the recruitment of 612 subjects two weeks ahead of the initially agreed schedule.

 

VIEW THE CASE STUDY!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Clinical Leader